Alphabet Inc’s Lyell Immunopharma LYEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$5.88M Hold
293,256
0.15% 20
2025
Q4
$9.03M Hold
293,256
0.35% 17
2025
Q3
$4.76M Hold
293,256
0.2% 22
2025
Q2
$2.59M Hold
293,256
0.12% 21
2025
Q1
$3.17M Hold
293,256
0.2% 23
2024
Q4
$3.75M Hold
293,256
0.22% 19
2024
Q3
$8.09M Hold
293,256
0.44% 17
2024
Q2
$8.5M Hold
293,256
0.43% 16
2024
Q1
$13.1M Hold
293,256
0.52% 14
2023
Q4
$11.4M Hold
293,256
0.53% 17
2023
Q3
$8.62M Hold
293,256
0.55% 18
2023
Q2
$18.7M Hold
293,256
1% 16
2023
Q1
$13.8M Hold
293,256
0.77% 19
2022
Q4
$20.4M Hold
293,256
1.18% 17
2022
Q3
$43M Hold
293,256
2.2% 12
2022
Q2
$38.2M Hold
293,256
2.08% 12
2022
Q1
$29.6M Hold
293,256
0.96% 17
2021
Q4
$45.4M Hold
293,256
1.1% 16
2021
Q3
$86.8M Hold
293,256
2.06% 11
2021
Q2
$95.3M Buy
+293,256
New +$96.2M 1.94% 8

Other funds holding LYEL